25C-NBOH

25C-NBOH (also known as 2C-C-NBOH and NBOH-2C-C) is a psychedelic phenethylamine derivative and a serotonin receptor agonist. It is closely related to the better-known compound 25I-NBOH and is part of the larger family of N-benzyl phenethylamine derivatives.

History

25C-NBOH was first synthesized by David E. Nichols at Purdue University. It was developed as a potential tool for neuroscience research, particularly in the study of 5-HT2A receptors, which are thought to be the primary target of psychedelic drugs.

Pharmacology

25C-NBOH acts as a highly potent partial agonist for the 5-HT2A receptor. It has been reported to have a high binding affinity for this receptor, which is thought to be the primary target of psychedelic drugs. The exact mechanisms of action and effects of 25C-NBOH are still not fully understood, and it is a topic of ongoing research.

Effects

The effects of 25C-NBOH can vary greatly depending on the dose, set, and setting. It is generally described as having a strong psychedelic effect, including visual hallucinations, changes in perception, and altered thought processes. Some users also report feelings of euphoria, increased empathy, and enhanced introspection. However, it can also cause negative effects such as anxiety, paranoia, and potentially dangerous changes in heart rate and blood pressure.

Legal Status

The legal status of 25C-NBOH varies by country. In some countries, it is a controlled substance, while in others it is legal to possess and use. It is important to note that even in countries where it is legal, it is still a potent and potentially dangerous drug that should be used with caution.

See Also

• 25I-NBOH
• 25B-NBOH
• 25D-NBOH
• Psychedelic drug
• Phenethylamine